Association between cannabis use with urological cancers: A population‐based cohort study and a mendelian randomization study in the UK biobank

Abstract Background Legislation of cannabis use has been approved in many European and North American countries. Its impact on urological cancers is unclear. This study was conducted to explore the association between cannabis use and the risk of urological cancers. Methods We identified 151,945 ind...

Full description

Bibliographic Details
Main Authors: Jingyi Huang, Da Huang, Xiaohao Ruan, Jinlun Huang, Danfeng Xu, Susan Heavey, Jonathan Olivier, Rong Na
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.5132
_version_ 1797903127834263552
author Jingyi Huang
Da Huang
Xiaohao Ruan
Jinlun Huang
Danfeng Xu
Susan Heavey
Jonathan Olivier
Rong Na
author_facet Jingyi Huang
Da Huang
Xiaohao Ruan
Jinlun Huang
Danfeng Xu
Susan Heavey
Jonathan Olivier
Rong Na
author_sort Jingyi Huang
collection DOAJ
description Abstract Background Legislation of cannabis use has been approved in many European and North American countries. Its impact on urological cancers is unclear. This study was conducted to explore the association between cannabis use and the risk of urological cancers. Methods We identified 151,945 individuals with information on cannabis use in the UK Biobank from 2006 to 2010. Crude and age‐standardized incidence ratios of different urological cancers were evaluated in the entire cohort and subgroups. Cox regression was performed for survival analysis. Results Previous use of cannabis was a significant protective factor for renal cell carcinoma (HR = 0.61, 95%CI:0.40–0.93, p = 0.021) and prostate cancer (HR = 0.82, 95%CI:0.73–0.93, p = 0.002) in multivariable analysis. The association between previous cannabis use and both renal cell carcinoma and bladder cancer was only observed in females (HRRCC = 0.42, 95%CI:0.19–0.94, p = 0.034; HRBCa = 0.43, 95%CI:0.21–0.86, p = 0.018) but not in men. There was no significant association between cannabis use and testicular cancer incidence. Mendelian randomization demonstrated a potential causal effect of cannabis use on a lower incidence of renal cell carcinoma. Conclusions Previous use of cannabis was associated with a lower risk of bladder cancer, renal cell carcinoma, and prostate cancer. The inverse association between cannabis and both renal cell carcinoma and bladder cancer was only found in females but not in males.
first_indexed 2024-04-10T09:28:04Z
format Article
id doaj.art-c2cbffe47a4945119645905a03bf60a1
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-04-10T09:28:04Z
publishDate 2023-02-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-c2cbffe47a4945119645905a03bf60a12023-02-19T18:54:08ZengWileyCancer Medicine2045-76342023-02-011233468347610.1002/cam4.5132Association between cannabis use with urological cancers: A population‐based cohort study and a mendelian randomization study in the UK biobankJingyi Huang0Da Huang1Xiaohao Ruan2Jinlun Huang3Danfeng Xu4Susan Heavey5Jonathan Olivier6Rong Na7Department of Urology Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Urology Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Urology Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Urology Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Urology Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai ChinaDivision of Surgery and Interventional Sciences University College London London UKDepartment of Urology, CHU Lille Claude Huriez Hospital, University of Lille Lille FranceDivision of Urology, Department of Surgery Queen Mary Hospital, The University of Hong Kong Hong KongAbstract Background Legislation of cannabis use has been approved in many European and North American countries. Its impact on urological cancers is unclear. This study was conducted to explore the association between cannabis use and the risk of urological cancers. Methods We identified 151,945 individuals with information on cannabis use in the UK Biobank from 2006 to 2010. Crude and age‐standardized incidence ratios of different urological cancers were evaluated in the entire cohort and subgroups. Cox regression was performed for survival analysis. Results Previous use of cannabis was a significant protective factor for renal cell carcinoma (HR = 0.61, 95%CI:0.40–0.93, p = 0.021) and prostate cancer (HR = 0.82, 95%CI:0.73–0.93, p = 0.002) in multivariable analysis. The association between previous cannabis use and both renal cell carcinoma and bladder cancer was only observed in females (HRRCC = 0.42, 95%CI:0.19–0.94, p = 0.034; HRBCa = 0.43, 95%CI:0.21–0.86, p = 0.018) but not in men. There was no significant association between cannabis use and testicular cancer incidence. Mendelian randomization demonstrated a potential causal effect of cannabis use on a lower incidence of renal cell carcinoma. Conclusions Previous use of cannabis was associated with a lower risk of bladder cancer, renal cell carcinoma, and prostate cancer. The inverse association between cannabis and both renal cell carcinoma and bladder cancer was only found in females but not in males.https://doi.org/10.1002/cam4.5132bladder cancercannabisincidenceprostate cancerrenal cell carcinomatesticular cancer
spellingShingle Jingyi Huang
Da Huang
Xiaohao Ruan
Jinlun Huang
Danfeng Xu
Susan Heavey
Jonathan Olivier
Rong Na
Association between cannabis use with urological cancers: A population‐based cohort study and a mendelian randomization study in the UK biobank
Cancer Medicine
bladder cancer
cannabis
incidence
prostate cancer
renal cell carcinoma
testicular cancer
title Association between cannabis use with urological cancers: A population‐based cohort study and a mendelian randomization study in the UK biobank
title_full Association between cannabis use with urological cancers: A population‐based cohort study and a mendelian randomization study in the UK biobank
title_fullStr Association between cannabis use with urological cancers: A population‐based cohort study and a mendelian randomization study in the UK biobank
title_full_unstemmed Association between cannabis use with urological cancers: A population‐based cohort study and a mendelian randomization study in the UK biobank
title_short Association between cannabis use with urological cancers: A population‐based cohort study and a mendelian randomization study in the UK biobank
title_sort association between cannabis use with urological cancers a population based cohort study and a mendelian randomization study in the uk biobank
topic bladder cancer
cannabis
incidence
prostate cancer
renal cell carcinoma
testicular cancer
url https://doi.org/10.1002/cam4.5132
work_keys_str_mv AT jingyihuang associationbetweencannabisusewithurologicalcancersapopulationbasedcohortstudyandamendelianrandomizationstudyintheukbiobank
AT dahuang associationbetweencannabisusewithurologicalcancersapopulationbasedcohortstudyandamendelianrandomizationstudyintheukbiobank
AT xiaohaoruan associationbetweencannabisusewithurologicalcancersapopulationbasedcohortstudyandamendelianrandomizationstudyintheukbiobank
AT jinlunhuang associationbetweencannabisusewithurologicalcancersapopulationbasedcohortstudyandamendelianrandomizationstudyintheukbiobank
AT danfengxu associationbetweencannabisusewithurologicalcancersapopulationbasedcohortstudyandamendelianrandomizationstudyintheukbiobank
AT susanheavey associationbetweencannabisusewithurologicalcancersapopulationbasedcohortstudyandamendelianrandomizationstudyintheukbiobank
AT jonathanolivier associationbetweencannabisusewithurologicalcancersapopulationbasedcohortstudyandamendelianrandomizationstudyintheukbiobank
AT rongna associationbetweencannabisusewithurologicalcancersapopulationbasedcohortstudyandamendelianrandomizationstudyintheukbiobank